Emory Proton Therapy Center completes treatment for 2022nd patient

In early 2022, the Emory Proton Therapy Center treated its 2022nd patient. Megan Smith never expected her headaches would lead to becoming that patient.

Raj receives American Cancer Society Research Scholar Grant

Winship member and Emory chemist Monika Raj, PhD, has received a four-year, $792,000 Research Scholar Grant from the American Cancer Society. The grant will support Raj’s research project focused on discovering new chemical approaches and novel markers for detecting early-stage lung cancer.

About the Raj Group

Boise elected to ASPET leadership

Lawrence Boise, PhD, Winship associate director for education and training, has been elected secretary/treasurer for the American Society for Pharmacology and Experimental Therapeutics’ division of cancer pharmacology. The society is the professional home for those working to advance pharmacology research, knowledge and impact.

View New ASPET Leaders

Emory announces Nursing Excellence Award winners

Twelve nurses who support Winship patients are the winners of this year's Emory Healthcare Nursing Excellence Awards. The awardees were announced by the Emory Healthcare Nursing Recruitment and Retention Council during National Nurses Week, May 6-12.

Video: Oncology Nursing Month spotlight with Monica Goodman

Meet Monica S. Goodman BSN, RN, OCN, a Winship nurse educator in the Phase 1 Unit. In this video, she talks about how the multidisciplinary approach to patient care attracted her to oncology nursing and her excitement for the future of cancer care that research advancements are making possible.

Watch Video

Registration opens for UGA-Winship Summit

The University of Georgia and Winship Summit, “Advancing Cancer Research in Georgia,” will be held July 17-18 at the Evergreen Marriott Conference Resort in Stone Mountain. Highlights include an opening night banquet with keynote talk, faculty presentations on emerging topics, and a poster session featuring student and trainee research. Registration is complimentary. Hotel accommodation requests are due June 15, and poster abstracts are due June 24.

“Can You Hear My Voice?” virtual film screening and webinar

Winship will host a free webinar on June 2 at 6 p.m. featuring the award-winning documentary film, “Can You Hear My Voice?” and a panel discussion with Winship throat cancer specialists, throat cancer survivors, and the film’s producer, Bill Brummel. Webinar registrants receive a link to a virtual screening of the film, viewable May 27 through June 5.

Call for proposals: 43 Challenge grants for pediatric cancer research

The 43 Challenge by the National Pediatric Cancer Foundation is open to new and innovative research proposals poised to significantly improve the lives of children with cancer. Proposals are valued at $1 million to $4.3 million and may be submitted by individuals or multidisciplinary teams. Applications are due May 31.

Learn More

Winship celebrates teams on Clinical Trials Day

Winship marked Clinical Trials Day on May 20 with a celebration honoring the more than 200 Winship Clinical Trials Office professionals who help clinical investigators conduct high-quality cancer research.

About Winship Clinical Trials

Below are four selected Winship publications out of 49 published over the past week:

Pollack A, Karrison TG, Balogh AG, Gomella LG, Low DA, Bruner DW, Wefel JS, Martin AG, Michalski JM, Angyalfi SJ, Lukka H, Faria SL, Rodrigues GB, Beauchemin MC, Lee RJ, Seaward SA, Allen AM, Monitto DC, Seiferheld W, Sartor O, Feng F, Sandler HM. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial. Lancet. 2022; 399(10338):1886-1901. PubMed PMID: 35569466.

View in PubMed

Sudmeier LJ, Hoang KB, Nduom EK, Wieland A, Neill SG, Schniederjan MJ, Ramalingam SS, Olson JJ, Ahmed R, Hudson WH. Distinct phenotypic states and spatial distribution of CD8+ T cell clonotypes in human brain metastases. Cell Reports Medicine. 2022; 3(5):100620. PubMed PMID: 35584630.

View in PubMed

Radovich M, Solzak JP, Wang CJ, Hancock BA, Badve SS, Althouse SK, Bray SM, Storniolo AM, Ballinger TJ, Schneider BP, Miller KD. Initial phase I safety study of gedatolisib plus cofetuzumab pelidotin for patients with metastatic triple-negative breast cancer. Clinical Cancer Research. 2022; PubMed PMID: 35551360.

View in PubMed

Tieniber AD, Shannon A, Carr MJ, Sun J, Landa K, Baecher KM, Lynch K, Bartels HG, Panchaud R, Lowe MC, Slingluff CL, Jameson MJ, Tsai KY, Faries MB, Beasley GM, Sondak VK, Karakousis GC, Zager JS, Miura JT. Patterns of Recurrence and Prognosis in Pathologic Stage I and II Merkel Cell Carcinoma: A multi-center, retrospective cohort analysis. Journal of the American Academy of Dermatology. 2022; PubMed PMID: 35588924.

View in PubMed